Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-18-0412
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Cotargeting Polo-Like Kinase 1 and the WNT/Β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2015English

Targeting TCTP as a New Therapeutic Strategy in Castration-Resistant Prostate Cancer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

Quantitative Analysis of Castration Resistant Prostate Cancer Progression Through Phosphoproteome Signaling

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Visceral Disease in Castration-Resistant Prostate Cancer

European Urology
Urology
2014English

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Yearbook of Paediatric Endocrinology
2019English

Mechanisms of Acquired Resistance to Androgen Receptor Targeting Drugs in Castration-Resistant Prostate Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2014English

Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway

Surgical Oncology Clinics of North America
SurgeryOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy